Experimental autoimmune encephalomyelitis (EAE) is a polygenic chronic inflammatory demyelinating disease of the nervous system, commonly used as an animal model of multiple sclerosis. Previous studies have identified multiple quantitative trait loci (QTLs) controlling different aspects of disease pathogenesis. However, direct genetic control of cortical motor evoked potentials (cMEPs) as a straightforward measure of extent of demyelination or synaptic block has not been investigated before. Here we examined the genetic control of different traits of EAE in a F2 intercross population generated from the EAE susceptible SJL/J (SJL) and the EAE resistant C57BL/10.S (B10.S) mouse strains involving 400 animals. The genotypes of 150 microsatellite markers were determined in each animal and correlated to phenotypic data of onset and severity of disease, cell infiltration and cMEPs. Nine QTLs were identified.
Introduction
Multiple sclerosis (MS) is a complex polygenic disease with prevalence dependent on age, gender, hormonal and environmental factors. Susceptibility to MS is influenced by genetic factors, as indicated by numerous studies showing higher rates of disease concordance in monozygotic than in dizygotic twins, and higher incidence in offspring of MS patients (1, 2) . The primary genetic contribution to MS susceptibility is thought to be linked to the HLA locus (1) . Identification of the non-MHC genetic loci regulating MS is a complex task due to genetic heterogeneity, incomplete penetrance and influence of environmental factors (3, 4) . Hence, genetic analysis of well-defined experimental models such as Experimental Autoimmune Encephalomyelitis (EAE) and the search of syntenic regions between different species in these susceptible loci (5) have the potential to accelerate the genetic analysis of MS (6) . In animals and humans most studies indicate that both non-MHC genes and MHC genes are associated with the susceptibility to EAE (7) . The first QTL identified, EAE1, is located on chromosome 17 and includes the MHC. Nevertheless, inbred strains sharing the same MHC haplotype vary in their susceptibility indicating the existence of non-MHC susceptibility genes. The conservative estimate for the number of non-MHC susceptibility genes involved is suggested to be more than thirty (8-10). In the past few years extensive search localized 28 QTLs that regulate EAE in mice, mostly in crosses involving the SJL/J and C57BL/10.S strains, both sharing the same H2 haplotype (11) .
We assumed that there could be additional QTLs that contribute to the susceptibility to EAE by controlling disease pathways that have not yet been identified. So we set out to identify such QTLs in a new wide genome screen of the F2 generation between C57BL/10.S and SJL/J strains. We focused on functional parameters of the central nervous system (CNS) of EAE mice as a primary trait. Impaired function reflected in electrophysiological changes was shown to be associated with disease severity and demyelination in earlier studies (12) . The deterioration of the myelin sheath is one of the main pathological characteristics during the disease and temporal dispersion of neuronal conduction due to demyelination can result in altered cortical evoked responses. CMEP provide by guest on April 29, 2016 http://hmg.oxfordjournals.org/ Downloaded from 6 spinal cords cylinders revealed no significant difference in the myelination pattern and axonal integrity, thus pointing towards a minor involvement of obvious demyelination at this stage of disease. However, the stains for microglia (IBA1), B and T lymphocytes (B220 and CD3) revealed differences between the individual animals ( Figure 4) . Two new QTLs related to the amount of infiltrating T-lymphocytes and microglia (Table 1, Figure 3) were identified on chromosome 8 (EAE36, linked to D8Mit259) and on chromosome 15 (EAE37, linked to D15Mit35) respectively.
A suggestive QTL associated to B-lymphocyte infiltration also map on chromosome 15 (EAE38, linked to D15Mit171) in a region associated to severity in males.
To validate the loci, a two-point analysis (F statistics, ANOVA) was performed (see supplementary Table 2 ).
Quantitative trait Loci associated with latencies of cortical motor evoked potential
In the light of the mismatch between severity and demyelination in the beginning of the disease we sought to determine a direct functional measure as provided by cortical motor evoked potentials (cMEP).
The cMEP consist on a biphasic wave following the stimulus at a mean latency of 2.66 ms for forelimb and 3.95 ms for hindlimb (Table 2) . Interestingly we observed differences in cMEP latencies between non-immunized parental strains (Table 2 , p < 0.05) indicating that susceptible mice already have greater latencies in both, hindlimb and forelimb. Following disease induction in the F2 generation, there was a considerable prolongation of latencies (Table 2, Figure 2) . A representative comparison between cMEP measured in a sick mouse at different time points during the disease is shown in figure 2 . As obvious, disease progression leads to a progressive delay in the cMEP onset accompanied by a scattering of the cMEP.
We choose the latency of cMEP as a trait since it appeared to be the most reproducible and reliable parameter for both, myelin disturbance and functional impairment. By doing this, we identified three EAE loci associated to this trait (Table 1, Figure 1) . A suggestive evidence of linkage on chromosome 1 (EAE 30) to marker D1Mit303 associated to the latency of cMEP 15 days after immunization (latency at day 15 recorded in the forelimb, LOD score of 3.4). The linkage became statistically significant only when severity as a covariance was used in the analysis (LOD 3.7, There is no overlap between QTL controlling histopathological changes and QTL controlling cMEP latencies.
A decrease of the incidence in mice used for the electrophysiology (42 %) comparing to the rest of F2 mice (58 %) was observed (χ 2 = 15.01 > 3.84) but disease severity and onset were not affected by the neurological procedure. The mean disease severity score in mice for electrophysiology was 2.72 ± 1.50 which did not differ from the whole group, 2.67 ± 1.29 (p = 0.8). The mean onset values in the electrophysiological group and the whole group were 13.31 ± 3.19 days and 12.98 ± 3.22 days, respectively (p = 0.8). To validate the loci, a two-point analysis (F statistics, ANOVA) was performed (see supplementary Table 2 ).
Association and correlation between QTLs influencing cortical motor evoked potentials and incidence, disease onset, disease severity and cell infiltration
To explore the relevance of cMEP controlling alleles we investigated their effect i.e their relationship to incidence onset and severity of disease, respectively as well as to cell infiltration 8 contributor to this association. In this case mice with both mild and severe disease show differences with respect to healthy mice (p = 0.036, p < 0.001 respectively). Furthermore mice with the SJL allele at this locus with B-lymphocyte infiltration in their spinal cords show slower conduction times than mice without infiltration (p < 0.001) (see supplementary Figure 2 ). EAE 31 linked to the forelimb cMEP latencies before immunization. This is reflected in the significant differences between the B10S and the SJL (D8Mit178) mice (p < 0.001). Mice with the SJL allele had longer latencies than mice with the B10S allele. Early onset associates with longer latencies (p = 0.018).
However, there was no association between the latencies before immunization and incidence or severity of the disease.
EAE 32 linked to the latency of cMEP in the hindlimb assessed by using the difference between the latencies at days 0and 15 as a phenotype. The association of this trait with incidence of disease was very strong (p < 0.001) and was independent on the allele carried by the mice (see Table 3 and 4).
We also observed differences in the latencies of cMEP between healthy mice with respect to mice suffering from mild disease and mice having severe disease (see Table 4 ). There is an association with severity showing that mice with severe disease had longer conduction times than mice presenting mild symptoms (p = 0.006). Regression analysis (Table 3) showed a good correlation between disease severity in mice with the B10S allele in this locus and latency of cMEP (R = 0.87 for B10S allele homozygous mice and R = 0.77 for mice with at least one copy of the B10S allele).
There is also an association with B-lymphocyte infiltration in spinal cords since the mice with infiltration showed slower conduction times (measured as a difference between day 0 and day 15) than mice without infiltration. Again mice with at least one copy of the B10S allele at D15Mit67 locus and B-lymphocytes infiltration have longer conduction times than mice without B lymphocyte infiltration (see supplementary Figure 2 ).
Discussion
The most important finding of this study is the identification of 3 new QTLs controlling the latency of cMEPs, a phenotype that functionally reflects the disease activity and provides quantitative data additional to the semi quantitative clinical severity data.
EAE 30 on chromosome 1, cM 11-32, controlled the latency of cMEP as recorded in the forelimb.
The linkage was disease dependent as significance was detected when using disease as a covariate in the analysis. This is concordant with the observation that the latency of forelimb cMEP was enhanced in diseased mice compared to healthy mice, with the SJL/J allele as the contributing allele. EAE 30 partially overlaps with an earlier described locus (Tmevd 6), which controls severity in Theiler´s murine encephalomyelitis, a virus-induced demyelinating disease (12) (13) (14) . It also overlaps with the Idd5a locus identified in the NOD mice as predisposing to Diabetes (15) where there is strong evidence that CTLA4 and/or ICOS (16) are the likely susceptibility gene for this locus.
EAE 31 locus on chromosome 8 cM 32-48 controlled the latency of cMEPs before immunization.
As shown for the EAE 30 the contributing allele originated from the susceptible strain, SJL/J, and had a dominant effect. A longer latency of cMEPs (measured in the forelimb) before immunization also correlates significantly with an earlier onset of the disease (p < 0.001). This suggests that at least one gene affecting axon structure, myelin composition or synapse transmission may predispose susceptible mice to an early onset of the disease. EAE 31 partially overlaps with the EAE 14 locus previously linked to incidence (9) of the disease and to demyelination (17). EAE 31 maps to a region that also contains several genes of putative relevance. One of those genes, the calcium channel alpha1 subunit gene (CACNA1a), encodes the alpha subunit of a P-type calcium channel (18-20). CACNA1a is associated with neurological symptoms in mice, like ataxia.
Furthermore, it is polymorphic and earlier studies show that it is differentially expressed during the course of EAE (21). Another interesting, but less likely contributing gene, Caspase 3, is involved in apoptotic death of different neuronal cells (22-24) where apoptosis is one of the pathways that leads to demyelination (25). Genes like the Janus kinase 3 (JAK3) and Carboxypeptidase E (CPE) are also putative contributors, although these genes cannot be linked to the phenotype studied. However both genes mapped to this interval are differentially expressed during the disease (26) and are polymorphic genes (27) (28) (29) (30) . CPE is a secretory granule enzyme involved in dibasic cleavage of proproteins and prohormones (31) whereas JAK3 is a tyrosine kinase involved in signal transduction processes (32).
The association between the susceptibility allele on chromosome 8 with a slower conduction and with an earlier onset of disease could have an important meaning because such a predictive allele could be used to screen populations at high risk of developing multiple sclerosis by the non invasive evoked potential measurements. This finding is supported by the fact that parental strain differences in cMEP latencies are already observed before immunization and are likely to be related to different myelin composition. Animals with attenuated biochemical properties of the myelin sheath may therefore be more prone to develop early EAE. The differences in cMEP measurements could unravel patients that show distinct alteration of the myelin sheath and it might therefore be a tool for either treatment monitoring or even risk assessment. Additionally to the cMEP QTLs, we identified new QTLs controlling traits like disease severity, disease onset and cell infiltration.
Two new QTLs on chromosomes 2 (D2Mit32) and 10 (D10Mit271) were associated with severity in females ( Table 1) . EAE 34 is a new QTL that although it partially overlaps with EAE 17, which has previously been shown to be associated with disease severity and spinal cord demyelination in females (9). EAE 33 on chromosome 2 represents a new locus that is mapped to the distal p- 
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Fig. 3 Comparison between published EAE loci and those QTL identified in this study
Red lines correspond to the 28 QTL described in the literature while green lines represent the QTL described in our study 
